All Things Chromatography

Food and Drug Administration Safety and Innovation Act highlighted

Members of Delaware's medical, pharma, and legislative communities gathered at the Helen F. Graham Cancer Center in Christiana Care Health System to discuss the U.S. Food and Drug Administration Safety and Innovation Act of 2012.

PDUFA Conf resized 600

The bill enables the FDA to collect fees from pharma companies to offset costs of regulatory reviews of biological products and drugs. The measure reauthorizes the Prescription Drug User Fee Act and Medical Device User Fee Act.

U.S. Senator Tom Carper issued the following statement:

"This bill helps ensure that Americans get access to the life-saving medications and medical devices that are developed in this country – including Delaware – as soon and as safely as possible," said Sen. Tom Carper. "It improves the Food and Drug Administration's ability to review and regulate drugs and medical devices for adults and children. This legislation also helps to protect patients' access to critical medicines by creating new programs to incentivize the development of new antibiotics and reduce drug shortages. Patients, health care providers, and the pharmaceutical and medical device industries will all benefit from a more responsive and effective Food and Drug Administration– a win-win for Delaware consumers and businesses."

and, our camera's were there to capture the conference:

 

 

 

Topics: Pharma, Senator Carper, FDA

U.S. Senator Tom Carper honored for job creation through innovation

wwfh1 resized 600We Work for Health Delaware (WWFH – DE) and the Delaware BioScience Association recognized U.S. Senator Tom Carper as a “Champion for Continued Jobs Creation Through Innovation.” Senator Carper’s support of key legislative issues impacting the biotech industry, such as the America Invents Act, speak volumes about his commitment to protecting jobs in Delaware. Delaware is an established leader in the biotechnology industry. It is home to some of the world’s largest biotech companies. These companies provide not only jobs and revenue, but also much needed research used to combat some of our most serious medical challenges. It’s important that we do all that we can to protect this industry, and the jobs it creates for our citizens. WWFH – DE and Delaware Bio thank Senator Carper for being a leader in the Senate on issues critical to the continued success of the biopharmaceutical and healthcare industries in Delaware and for being champion of innovation.

Here's our message to Senator Carper:

and some more photos from the event held on Friday, December 9, 2011:

 

wwfh crowd resized 600

wwfh 4

Topics: Delaware BioScience Association, Delaware, Senator Carper, We Work For Health